Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

  • M. Somlyay
  • , E. Durinikova
  • , J. Besnard
  • , O. Barbeau
  • , J. Le Coz
  • , M. Senekowitsch
  • , B. Ergüner
  • , K. Hackner
  • , L. Dzurillova
  • , E. Petru
  • , J. Lafleur
  • , J. Singer
  • , T. Füreder
  • , R. Paveley
  • , J. Joseph
  • , F. Aswad
  • , T. Winkler-Penz
  • , R. Sehlke
  • , C. Boudesco
  • , G. Vladimer

Research output: Journal article (peer-reviewed)Conference contribution to journal

Original languageEnglish
Pages (from-to)S44-S45
JournalEuropean Journal of Cancer
Volume174
DOIs
Publication statusPublished - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this